Pssst. Did you hear that 14 papers were published in January of 2022 on treatments targeting synaptic and neuronal protection in Alzheimer's disease? Anusha has you covered with papers targeting amyloid-beta-induced cytotoxocity, demyelination, and cognitive dysfunction in animal models.
Sections in this episode:
Treatments using stem cells (2.18)
Protecting against A-beta induced toxicity (4.59)
Protecting against glutamate-induced cytotoxicity (9.20)
Treatments tested in transgenic AD-like mice (12.38)
Treatments tested in AD rat models (17.13)